Methods and Systems for Measurement of Tear Glucose Levels

• US 20130008803A1
• Filed: 01/03/2012
• Published: 01/10/2013
• Est. Priority Date: 01/03/2011
• Status: Abandoned Application

• Current Assignee: Eyelab Group, LLC, Board of Regents of the University of Michigan (University of Michigan)
• Original Assignee: Eyelab Group, LLC, Board of Regents of the University of Michigan (University of Michigan)
• Inventors: Meyerhoff, Mark E., Cohan, Bruce E., Flanders, Zvi, Yan, Qinyi, Peng, Bo
• Application Number:
  US13/342,634
• Publication Number:
  US 20130008803A1
• Time in Patent Office: Days
• US Class Current: 205/777.5
• CPC Class Codes: A61B 5/1486 using enzyme electrodes, e.g. with immobilised oxidase
• CPC Class Codes: G01N 27/3271 Amperometric enzyme electrodes for analytes in body fluids, e.g. glucose in blood amperometry per se G01N27/49; aspects concerning the enzyme reagent C12Q1/001

Abstract

A sensor system for determining glucose concentration in a tear fluid sample includes a working electrode including an immobilized glucose oxidase enzyme portion for reacting with glucose in the tear fluid sample, and a selectivity portion for enhancing the selectivity for glucose over electroactive interferent species in the tear fluid sample. Alternatively, a vessel for receiving the tear fluid sample may include the enzyme portion on an inner wall thereof. A reference electrode is disposed adjacent the working electrode, wherein the electrochemical reaction of the enzyme portion with glucose in the tear fluid sample generates a current related to the glucose concentration in the tear fluid sample.

Claims

1. A sensor for determining glucose concentration in a tear fluid sample, comprising:

a working electrode including an immobilized glucose oxidase enzyme portion for reacting with glucose in the tear fluid sample, and a selectivity portion for enhancing the selectivity for glucose over electroactive interferent species in the tear fluid sample; and

a reference electrode disposed adjacent the working electrode;

wherein the electrochemical reaction of the enzyme portion with glucose in the tear fluid sample generates a current related to the glucose concentration in the tear fluid sample.

2. The sensor of claim 1, wherein the working electrode comprises a Pt/Ir wire.

3. The sensor of claim 1, wherein the reference electrode comprises an Ag/AgCl wire wrapped around the working electrode.

4. The sensor of claim 1, wherein the selectivity portion is disposed beneath the enzyme portion.

5. The sensor of claim 1, wherein the enzyme portion and the selectivity portion are disposed in a cavity in the working electrode spaced upstream from an end thereof.

6. The sensor of claim 1, wherein the enzyme portion and the selectivity portion are disposed in a cavity in the working electrode disposed at an end thereof.

7. The sensor of claim 1, wherein the selectivity portion comprises coatings including NAFION®

cation exchange polymer and an electropolymerized film of 1,3-diaminobenzene and resorcinol.

8. The sensor of claim 1, wherein the working electrode is not provided with any membrane to restrict diffusion of glucose to the enzyme portion.

9. The sensor of claim 1, wherein the sensor is amperometric such that a steady-state current is generated that is proportional to the concentration of glucose in the tear fluid sample.

10. The sensor of claim 1, wherein the sensor is coulometric such that a total charge generated is proportional to the concentration of glucose in the tear fluid sample.

11. The sensor of claim 10, wherein consumption of glucose in the tear fluid sample is temperature-dependent, such that a time required for total charge detection is decreased with increased temperature.

12. The sensor of claim 1, wherein the sensor is capable of achieving a detection limit of about 1.5 μ

M of glucose in the tear fluid sample.

13. The sensor of claim 1, wherein a volume of the tear fluid sample required is about 3 μ

L or less.

14. A system for determining glucose concentration in a tear fluid sample, comprising:

a vessel for receiving the tear fluid sample, the vessel including an immobilized glucose oxidase enzyme portion on an inner wall thereof for reacting with glucose in the tear fluid sample; and

a sensor comprising a working electrode including a selectivity portion for enhancing the selectivity for glucose over electroactive interferent species in the tear fluid sample, and a reference electrode disposed adjacent the working electrode;

wherein the electrochemical reaction of the enzyme portion with glucose in the tear fluid sample generates a current related to the glucose concentration in the tear fluid sample.

15. The system of claim 14, wherein the working electrode comprises a Pt/Ir wire.

16. The system of claim 14, wherein the reference electrode comprises an Ag/AgCl wire wrapped around the working electrode.

17. The system of claim 14, wherein the selectivity portion comprises coatings including NAFION®

cation exchange polymer and an electropolymerized film of 1,3-diaminobenzene and resorcinol.

18. The system of claim 14, wherein the sensor is coulometric such that a total charge generated is proportional to the concentration of glucose in the tear fluid sample.

19. The system of claim 18, wherein consumption of glucose in the tear fluid sample is temperature-dependent, such that a time required for total charge detection is decreased with increased temperature.

20. The system of claim 14, wherein the sensor is capable of achieving a detection limit of about 1.5 μ

M of glucose in the tear fluid sample.

21. The system of claim 14, wherein a volume of the tear fluid sample required is about 3 μ

L or less.

22. A method for determining glucose concentration in a tear fluid sample, comprising:

providing a sensor system including a vessel for receiving a tear fluid sample, a working electrode including a selectivity portion for enhancing the selectivity for glucose over electroactive interferent species in the tear fluid sample, a reference electrode disposed adjacent the working electrode, and an immobilized glucose oxidase enzyme portion disposed on one of the working electrode and the vessel, the enzyme portion for reacting with glucose in the tear fluid sample; and

electrochemically reacting the enzyme portion with glucose in the tear fluid sample to generate a current related to the glucose concentration in the tear fluid sample.

23. The method of claim 22, wherein the working electrode comprises a Pt/Ir wire.

24. The method of claim 22, wherein the reference electrode comprises an Ag/AgCl wire wrapped around the working electrode.

25. The method of claim 22, wherein the selectivity portion comprises coatings including NAFION®

cation exchange polymer and an electropolymerized film of 1,3-diaminobenzene and resorcinol.

26. The method of claim 22, wherein reacting the enzyme portion includes generating a steady-state current that is proportional to the concentration of glucose in the tear fluid sample.

27. The method of claim 22, wherein reacting the enzyme portion includes generating a total charge that is proportional to the concentration of glucose in the tear fluid sample.

28. The method of claim 27, further comprising increasing the temperature to increase the consumption of glucose in the tear fluid sample and correspondingly decrease a time required for total charge detection.

29. The method of claim 22, wherein reacting the enzyme portion includes achieving a detection limit of about 1.5 μ

M of glucose in the tear fluid sample.

30. The method of claim 22, wherein a volume of the tear fluid sample required is about 3 μ

L or less.